Controlled release metformin compositions

CAFC
  • US 6,866,866 B1
  • Filed: 11/03/2000
  • Issued: 03/15/2005
  • Est. Priority Date: 11/03/2000
  • Status: Expired due to Term
First Claim
Patent Images

1. A controlled release oral dosage form for the reduction of serum glucose levels in human patients with NIDDM, comprising an effective dose of metformin or a pharmaceutically acceptable salt thereof and a controlled-release carrier to control the release of said metformin or pharmaceutically acceptable salt thereof from said dosage form, said dosage form being suitable for providing once-a-day oral administration of the metformin or pharmaceutically acceptable salt thereof, wherein following oral administration of a single dose, the dosage form provides a mean time to maximum plasma concentration (Tmax) of the metformin from 5.5 to 7.5 hours after administration following dinner.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×